Tumour-infiltrating lymphocytes: A prognostic factor of psa-free survival in patients with local prostate carcinoma treated by radical prostatectomy

Anticancer Research

Volumn 25, Issue 6 C, 2005, Pages 4435-4438

  Kärjä, Vesa ^a   Aaltomaa, Sirpa ^a   Lipponen, Pertti ^b   Isotalo, Taina ^c   Talja, Martti ^c   Mokka, Risto ^c  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

Author keywords

CD20; CD4; CD8; Prostate carcinoma; PSA; Tumour infiltrating lymphocytes

Indexed keywords

ANTIBODY; CD20 ANTIBODY; CD20 ANTIGEN; CD4 ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; GLEASON SCORE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; PROSTATECTOMY; T LYMPHOCYTE; TISSUE MICROARRAY; TUMOR ASSOCIATED LEUKOCYTE;

CD8-POSITIVE T-LYMPHOCYTES; DISEASE-FREE SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 28444496629     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Farkas A, Marcella S and Rhoads GG: Ethnic and racial differences in prostate cancer incidence and mortality. Ethn Dis 10: 69-75, 2000.
2. Balch CM, Riley LB, Bae YJ, Salmeron MA, Platsoucas CD, von Eschenbach A and Itoh K: Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch Surg 125: 200-205, 1990.
3. Vesalainen S, Lipponen P, Talja M and Syrjanen K: Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. Eur J Cancer 30A: 1797-1803, 1994.
4. Eerola AK, Soini Y and Paakko P: A high number of tumor-infiltrating lymphocytes are associated with a small tumor size, low tumor stage, and a favorable prognosis in operated small cell lung carcinoma. Clin Cancer Res 6: 1875-1881, 2000.
5. Fukunaga A, Miyamoto M and Cho Y et al: CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma. Pancreas 28: e26-31, 2004.
6. Marsigliante S, Biscozzo L, Marra A, Nicolardi G, Leo G, Lobreglio GB and Storelli C: Computerised counting of tumour infiltrating lymphocytes in 90 breast cancer specimens. Cancer Lett 139: 33-41, 1999.
7. Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E and Kosma VM: Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 182: 318-324, 1997.
8. Nguyen T, Naziruddin B, Dintzis S, Doherty GM and Mohanakumar T: Recognition of breast cancer-associated peptides by tumor-reactive, HLA-class I restricted allogeneic cytotoxic T lymphocytes. Int J Cancer 81: 607-615, 1999.
9. Carlos TM: Leukocyte recruitment at sites of tumor: dissonant orchestration. J Leukoc Biol 70: 171-184, 2001.
10. Appay V, Zaunders JJ and Papagno L et al: Characterization of CD4(+) CTLs ex vivo. J Immunol 168: 5954-5958, 2002.
11. Trinchieri G: Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13: 251-276, 1995.
12. Riemann D, Wenzel K, Schulz T, Hofmann S, Neef H, Lautenschlager C and Langner J: Phenotypic analysis of T lymphocytes isolated from non-small-cell lung cancer. Int Arch Allergy Immunol 114: 38-45, 1997.
13. UICC International Union Against Cancer: TNM Classification of Malignant Tumours, 2002.
14. Gleason DF and the Veterans Administration Cooperative Urological Research Group: Histologic grading and staging of prostatic carcinoma, 171-187, 1977.
15. Foss FM: Immunologic mechanisms of antitumor activity. Semin Oncol 29: 5-11, 2002.
16. Blumenfeld W, Tucci S and Narayan P: Incidental lymphocytic prostatitis. Selective involvement with nonmalignant glands. Am J Surg Pathol 16: 975-981, 1992.
17. Bostwick DG, de la Roza G, Dundore P, Corica FA and Iczkowski KA: Intraepithelial and stromal lymphocytes in the normal human prostate. Prostate 55: 187-193, 2003.
18. Blacklock NJ: The anatomy of the prostate: relationship with prostatic infection. Infection 19(Suppl 3): S111-114, 1991.
19. McClinton S, Miller ID and Eremin O: An immunohistochemical characterisation of the inflammatory cell infiltrate in benign and malignant prostatic disease. Br J Cancer 61: 400-403,1990.
20. Lipponen PK, Eskelinen MJ, Jauhiainen K, Harju E and Terho R: Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer. Eur J Cancer 29A: 69-75, 1992.